Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Impact of the Change in ESC Guidelines on Clinical Characteristics and Outcomes of Cardiogenic Shock Patients Receiving IABP Therapy.

Nevzorov R, Daum A, Jafari J, Yosefy C, Gallego-Colon E.

Cardiovasc Revasc Med. 2020 Jan;21(1):46-51. doi: 10.1016/j.carrev.2019.09.014. Epub 2019 Oct 22.

PMID:
31759912
2.

Difference in left atrial appendage remodeling between diabetic and nondiabetic patients with atrial fibrillation.

Yosefy C, Pery M, Nevzorov R, Piltz X, Osherov A, Jafari J, Beeri R, Gallego-Colon E, Daum A, Khalameizer V.

Clin Cardiol. 2020 Jan;43(1):71-77. doi: 10.1002/clc.23292. Epub 2019 Nov 22.

3.

Goblet cell carcinoid of the appendix: Two case reports and a review of the literature.

Livoff A, Asna N, Gallego-Colon E, Daum AZ, Harkovsky T, Schaffer M.

Mol Clin Oncol. 2019 Nov;11(5):493-497. doi: 10.3892/mco.2019.1921. Epub 2019 Sep 11.

4.

Low High-Density Lipoprotein Cholesterol Predisposes to Coronary Artery Ectasia.

Jafari J, Daum A, Hamed JA, Osherov A, Orlov Y, Yosefy C, Gallego-Colon E.

Biomedicines. 2019 Oct 7;7(4). pii: E79. doi: 10.3390/biomedicines7040079.

5.

Increased serum levels of Galectin-9 in patients with chronic lymphocytic leukemia.

Wdowiak K, Gallego-Colon E, Francuz T, Czajka-Francuz P, Ruiz-Agamez N, Kubeczko M, Grochoła I, Wybraniec MT, Chudek J, Wojnar J.

Oncol Lett. 2019 Jan;17(1):1019-1029. doi: 10.3892/ol.2018.9656. Epub 2018 Nov 1.

6.

Exenatide modulates expression of metalloproteinases and their tissue inhibitors in TNF-α stimulated human retinal pigment epithelial cells.

Garczorz W, Gallego-Colon E, Kosowska A, Siemianowicz K, Kłych-Ratuszny A, Woźniak M, Aghdam MRF, Francuz T, Dorecka M.

Pharmacol Rep. 2019 Feb;71(1):175-182. doi: 10.1016/j.pharep.2018.10.003. Epub 2018 Oct 3.

PMID:
30554037
7.

Incretin drugs as modulators of atherosclerosis.

Gallego-Colon E, Wojakowski W, Francuz T.

Atherosclerosis. 2018 Nov;278:29-38. doi: 10.1016/j.atherosclerosis.2018.09.011. Epub 2018 Sep 14. Review.

PMID:
30248550
8.

Pacemaker lead endocarditis: A rare cause of relapsing brucellosis.

Tsyba E, Gallego-Colon E, Daum AZ, Fishman E, Chaim Y.

IDCases. 2018 Aug 2;13:e00431. doi: 10.1016/j.idcr.2018.e00431. eCollection 2018.

9.

Exenatide modulates metalloproteinase expression in human cardiac smooth muscle cells via the inhibition of Akt signaling pathway.

Gallego-Colon E, Klych-Ratuszny A, Kosowska A, Garczorz W, Aghdam MRF, Wozniak M, Francuz T.

Pharmacol Rep. 2018 Feb;70(1):178-183. doi: 10.1016/j.pharep.2017.10.003. Epub 2017 Oct 4.

PMID:
29414148
10.

Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.

Wdowiak K, Francuz T, Gallego-Colon E, Ruiz-Agamez N, Kubeczko M, Grochoła I, Wojnar J.

Int J Mol Sci. 2018 Jan 10;19(1). pii: E210. doi: 10.3390/ijms19010210. Review.

11.

Erratum: Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.

Gallego-Colon E, Villalba M, Tonkin J, Cruz F, Bernal JA, Jimenez-Borregureo LJ, Schneider MD, Lara-Pezzi E, Rosenthal N.

NPJ Regen Med. 2017 Oct 20;2:17001. doi: 10.1038/npjregenmed.2017.1. eCollection 2017.

12.

Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation.

Garczorz W, Gallego-Colon E, Kosowska A, Kłych-Ratuszny A, Woźniak M, Marcol W, Niesner KJ, Francuz T.

Cardiovasc Ther. 2018 Apr;36(2). doi: 10.1111/1755-5922.12317. Epub 2018 Jan 24.

PMID:
29283509
13.

TSPO mutations in rats and a human polymorphism impair the rate of steroid synthesis.

Owen DR, Fan J, Campioli E, Venugopal S, Midzak A, Daly E, Harlay A, Issop L, Libri V, Kalogiannopoulou D, Oliver E, Gallego-Colon E, Colasanti A, Huson L, Rabiner EA, Suppiah P, Essagian C, Matthews PM, Papadopoulos V.

Biochem J. 2017 Nov 21;474(23):3985-3999. doi: 10.1042/BCJ20170648.

14.

Exenatide modulates tumor-endothelial cell interactions in human ovarian cancer cells.

Kosowska A, Gallego-Colon E, Garczorz W, Kłych-Ratuszny A, Aghdam MRF, Woz Niak M, Witek A, Wróblewska-Czech A, Cygal A, Wojnar J, Francuz T.

Endocr Connect. 2017 Nov;6(8):856-865. doi: 10.1530/EC-17-0294. Epub 2017 Oct 17.

15.

Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.

Gallego-Colon E, Villalba M, Tonkin J, Cruz F, Bernal JA, Jimenez-Borregureo LJ, Schneider MD, Lara-Pezzi E, Rosenthal N.

NPJ Regen Med. 2016 Jun 9;1:16001. doi: 10.1038/npjregenmed.2016.1. eCollection 2016. Erratum in: NPJ Regen Med. 2017 Oct 20;2:17001.

16.

Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction.

Gallego-Colon E, Sampson RD, Sattler S, Schneider MD, Rosenthal N, Tonkin J.

Mediators Inflamm. 2015;2015:484357. doi: 10.1155/2015/484357. Epub 2015 Sep 30.

17.

Monocyte/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization.

Tonkin J, Temmerman L, Sampson RD, Gallego-Colon E, Barberi L, Bilbao D, Schneider MD, Musarò A, Rosenthal N.

Mol Ther. 2015 Jul;23(7):1189-1200. doi: 10.1038/mt.2015.66. Epub 2015 Apr 21.

Supplemental Content

Loading ...
Support Center